DocSym
β
Searchsearch
Search
(L90.2) Anetoderma of jadassohn-pellizzari
More details coming soon
314 686 in individuals diagnosis anetoderma of jadassohn-pellizzari confirmed
Diagnosis anetoderma of jadassohn-pellizzari is diagnosed Women are 39.31% more likely than Men
95 498
Men receive the diagnosis anetoderma of jadassohn-pellizzari
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
219 188
Women receive the diagnosis anetoderma of jadassohn-pellizzari
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease anetoderma of jadassohn-pellizzari - Men aged 25-29 and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features anetoderma of jadassohn-pellizzari
Absence or low individual and public risk
Anetoderma of jadassohn-pellizzari - what does this mean
Anetoderma of jadassohn-pellizzari is a rare skin disorder characterized by the presence of round to oval, atrophic, hypopigmented or hyperpigmented macules, which can occur anywhere on the body. it is thought to be caused by a combination of an autoimmune response and an alteration in the elastic fibers of the dermis.
What happens during the disease - anetoderma of jadassohn-pellizzari
Anetoderma of jadassohn-pellizzari is thought to be caused by a disruption of the elastic fibers in the dermis of the skin. this disruption can be caused by a variety of factors, including inflammatory processes, autoimmune conditions, and genetic mutations. it is believed that the disruption of the elastic fibers causes the skin to become thin and weak, resulting in the formation of flaccid, atrophic skin lesions.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the affected area
- Skin biopsy to confirm the diagnosis
- Blood tests to check for any underlying causes
- Imaging tests, such as X-rays, to look for any other abnormalities
- Treatment with topical steroids or other medications
- Surgical excision of the affected area
Treatment and Medical Assistance
Main Goal of Treatment: To reduce inflammation and improve the appearance of skin lesions.
- Administer topical corticosteroids to reduce inflammation.
- Prescribe oral corticosteroids to reduce inflammation and improve the appearance of skin lesions.
- Prescribe topical retinoids to reduce inflammation and improve the appearance of skin lesions.
- Prescribe oral retinoids to reduce inflammation and improve the appearance of skin lesions.
- Administer intralesional corticosteroids to reduce inflammation and improve the appearance of skin lesions.
- Prescribe phototherapy to reduce inflammation and improve the appearance of skin lesions.
- Prescribe immunosuppressants to reduce inflammation and improve the appearance of skin lesions.
- Prescribe antifungals to reduce inflammation and improve the appearance of skin lesions.
- Prescribe antibiotics to reduce inflammation and improve the appearance of skin lesions.
- Prescribe antihistamines to reduce inflammation and improve the appearance of skin lesions.
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Anetoderma of jadassohn-pellizzari - Prevention
The best way to prevent anetoderma of jadassohn-pellizzari is to avoid any known triggers such as exposure to uv radiation, trauma, or certain medications. it is also important to practice good skin hygiene, such as avoiding harsh soaps and using a gentle cleanser, and to keep the skin well moisturized. avoiding tight clothing or jewelry that rubs against the skin can also help to prevent this condition.